Machine Learning in Drug Metabolism Study

被引:3
|
作者
Sinha, Krishnendu [1 ]
Ghosh, Jyotirmoy [2 ]
Sil, Parames Chandra [3 ,4 ]
机构
[1] Jhargram Raj Coll, Dept Zool, Jhargram 721507, India
[2] Banwarilal Bhalotia Coll, Dept Chem, Asansol 713303, India
[3] Bose Inst, Dept Div Mol Med, Kolkata 700054, India
[4] Bose Inst, Div Mol Med, Kolkata 700054, India
关键词
Machine learning; algorithms; deep learning; drug metabolism; metabolites; molecular docking; PHASE-I; PREDICTION; FUTURE; MECHANISMS; DISCOVERY; TOXICITY; NETWORK; MODELS; WEB;
D O I
10.2174/1389200224666221227094144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic reactions in the body transform the administered drug into metabolites. These metabolites exhibit diverse biological activities. Drug metabolism is the major underlying cause of drug overdose-related toxicity, adversative drug effects and the drug's reduced efficacy. Though metabolic reactions deactivate a drug, drug metabolites are often considered pivotal agents for off-target effects or toxicity. On the other side, in combination drug therapy, one drug may influence another drug's metabolism and clearance and is thus considered one of the primary causes of drug-drug interactions. Today with the advancement of machine learning, the metabolic fate of a drug candidate can be comprehensively studied throughout the drug development procedure. Naive Bayes, Logistic Regression, k-Nearest Neighbours, Decision Trees, different Boosting and Ensemble methods, Support Vector Machines and Artificial Neural Network boosted Deep Learning are some machine learning algorithms which are being extensively used in such studies. Such tools are covering several attributes of drug metabolism, with an emphasis on the prediction of drug-drug interactions, drug-target-interactions, clinical drug responses, metabolite predictions, sites of metabolism, etc. These reports are crucial for evaluating metabolic stability and predicting prospective drug-drug interactions, and can help pharmaceutical companies accelerate the drug development process in a less resource-demanding manner than what in vitro studies offer. It could also help medical practitioners to use combinatorial drug therapy in a more resourceful manner. Also, with the help of the enormous growth of deep learning, traditional fields of computational drug development like molecular interaction fields, molecular docking, quantitative structure-to-activity relationship (QSAR) studies and quantum mechanical simulations are producing results which were unimaginable couple of years back. This review provides a glimpse of a few contextually relevant machine learning algorithms and then focuses on their outcomes in different studies.
引用
收藏
页码:1012 / 1026
页数:15
相关论文
共 50 条
  • [21] Survey of Machine Learning Techniques in Drug Discovery
    Stephenson, Natalie
    Shane, Emily
    Chase, Jessica
    Rowland, Jason
    Ries, David
    Justice, Nicola
    Zhang, Jie
    Chan, Leong
    Cao, Renzhi
    CURRENT DRUG METABOLISM, 2019, 20 (03) : 185 - 193
  • [22] In Silico Machine Learning Methods in Drug Development
    Dobchev, Dimitar A.
    Pillai, Girinath G.
    Karelson, Mati
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (16) : 1913 - 1922
  • [23] Machine learning directed drug formulation development
    Bannigan, Pauric
    Aldeghi, Matteo
    Bao, Zeqing
    Hase, Florian
    Aspuru-Guzik, Alan
    Allen, Christine
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 175
  • [24] Machine learning approaches for drug combination therapies
    Paltun, Betul Guvenc
    Kaski, Samuel
    Mamitsuka, Hiroshi
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (06)
  • [25] eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates
    Pu, Limeng
    Naderi, Misagh
    Liu, Tairan
    Wu, Hsiao-Chun
    Mukhopadhyay, Supratik
    Brylinski, Michal
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
  • [26] Supervised machine learning in drug discovery and development: Algorithms, applications, challenges, and prospects
    Obaido, George
    Mienye, Ibomoiye Domor
    Egbelowo, Oluwaseun F.
    Emmanuel, Ikiomoye Douglas
    Ogunleye, Adeola
    Ogbuokiri, Blessing
    Mienye, Pere
    Aruleba, Kehinde
    MACHINE LEARNING WITH APPLICATIONS, 2024, 17
  • [27] Machine Learning for Classification of Inhibitors of Hepatic Drug Transporters
    Khuri, Natalia
    Deshmukh, Shantanu
    2018 17TH IEEE INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), 2018, : 181 - 186
  • [28] A review on machine learning approaches and trends in drug discovery
    Carracedo-Reboredo, Paula
    Linares-Blanco, Jose
    Rodriguez-Fernandez, Nereida
    Cedron, Francisco
    Novoa, Francisco J.
    Carballal, Adrian
    Maojo, Victor
    Pazos, Alejandro
    Fernandez-Lozano, Carlos
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 4538 - 4558
  • [29] Machine Learning and Deep Learning Techniques Applied to Diabetes Research: A Bibliometric Analysis
    Garcia-Jaramillo, Maira
    Luque, Carolina
    Leon-Vargas, Fabian
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, : 287 - 301
  • [30] Machine learning in geography-Past, present, and future
    Lavallin, Abigail
    Downs, Joni A.
    GEOGRAPHY COMPASS, 2021, 15 (05):